Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11050 | 31067824 | J Clin Med | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors. | 2019 | Details |
| A11055 | 31064105 | J Clin Med | Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2019 | Details |
| A11057 | 31064058 | Int J Mol Sci | Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11069 | 31060668 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Associations of Non-alcoholic Fatty Liver Disease with Prevalence,Severity,and Prognosis of Coronary Heart Disease]. | 2019 | Details |
| A11081 | 31054837 | Prim Care Diabetes | Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. | 2019 | Details |
| A11083 | 31051410 | Atherosclerosis | The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events. | 2019 | Details |
| A11094 | 31045630 | Eur J Gastroenterol Hepatol | Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease. | 2019 | Details |
| A11113 | 31035998 | BMC Med | Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity. | 2019 | Details |
| A11125 | 31031702 | Front Endocrinol (Lausanne) | The Discovery and Development of Liraglutide and Semaglutide. | 2019 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11158 | 31018673 | Angiology | The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease. | 2019 | Details |
| A11177 | 31010049 | Int J Mol Sci | Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. | 2019 | Details |
| A11194 | 31004758 | Clin Gastroenterol Hepatol | Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies. | 2019 | Details |
| A11197 | 31004037 | J Biol Chem | Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice. | 2019 | Details |
| A11204 | 31000862 | J Pak Med Assoc | Expert Opinion: Use of sodium glucose co-transporter type-2 inhibitors in South Asian population -The Pakistan perspective. | 2019 | Details |
| A11209 | 30998190 | Ann Biol Clin (Paris) | [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker]. | 2019 | Details |
| A11216 | 30991959 | BMC Gastroenterol | Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. | 2019 | Details |
| A11250 | 30973968 | Br J Clin Pharmacol | Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11261 | 30970434 | Gut Liver | Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11267 | 30968536 | Liver Int | Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study. | 2019 | Details |
| A11279 | 30961499 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. | 2020 | Details |
| A11292 | 30952479 | J Formos Med Assoc | Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. | 2019 | Details |
| A11299 | 30949764 | World J Surg | Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome. | 2019 | Details |
| A11343 | 30929342 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of single-nucleotide polymorphism in theTM6SF2 rs58542926]. | 2019 | Details |
| A11344 | 30929337 | Zhonghua Gan Zang Bing Za Zhi | [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease]. | 2019 | Details |
| A11365 | 30920975 | Eur J Gastroenterol Hepatol | Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11373 | 30919338 | Adv Exp Med Biol | Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases. | 2019 | Details |
| A11376 | 30919112 | Heart Vessels | High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes. | 2019 | Details |
| A11378 | 30918873 | J Diabetes Metab Disord | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. | 2018 | Details |
| A11383 | 30917662 | Rev Esp Enferm Dig | Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype. | 2019 | Details |
| A11402 | 30912099 | Semin Liver Dis | Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics. | 2019 | Details |
| A11407 | 30907181 | Scand J Gastroenterol | Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11421 | 30901317 | Rom J Intern Med | Non-alcoholic fatty pancreas disease - practices for clinicians. | 2019 | Details |
| A11429 | 30898592 | Sex Med Rev | Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems. | 2019 | Details |
| A11430 | 30897538 | Biomed Pharmacother | Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease. | 2019 | Details |
| A11445 | 30892481 | Sao Paulo Med J | Association of alanine aminotransferase concentration with cardiometabolic risk factors in children and adolescents: the CASPIAN-V cross-sectional study. | 2019 | Details |
| A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11456 | 30888594 | Adv Ther | Pharmacological Treatment for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11467 | 30883738 | J Physiol | Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. | 2019 | Details |
| A11479 | 30878840 | Atherosclerosis | Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey. | 2018 | Details |
| A11488 | 30875495 | Atherosclerosis | Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. | 2019 | Details |
| A11489 | 30875494 | Atherosclerosis | Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. | 2019 | Details |
| A11490 | 30875479 | Expert Rev Gastroenterol Hepatol | Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. | 2019 | Details |
| A11509 | 30867626 | Fed Pract | Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? | 2019 | Details |
| A11532 | 30854694 | Aliment Pharmacol Ther | Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. | 2019 | Details |
| A11563 | 30838350 | Acta Myol | Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophy. | 2018 | Details |
| A11564 | 30837878 | Front Pharmacol | G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases. | 2019 | Details |
| A11568 | 30836450 | Aliment Pharmacol Ther | Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume. | 2019 | Details |
| A11571 | 30835188 | Radiology | Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. | 2019 | Details |
| A11583 | 30829918 | Clin Transl Gastroenterol | Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case-Control Study. | 2019 | Details |
| A11589 | 30827909 | Endocrinol Diabetes Nutr (Engl Ed) | Document on a comprehensive approach to type 2 diabetes mellitus. | 2019 | Details |
| A11605 | 30822462 | Prog Lipid Res | Plant-based sterols and stanols in health & disease: "Consequences of human development in a plant-based environment?" | 2019 | Details |
| A11613 | 30819364 | J Am Coll Cardiol | Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. | 2019 | Details |
| A11626 | 30813440 | Nutrients | Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial. | 2019 | Details |
| A11636 | 30809932 | Liver Int | Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients. | 2019 | Details |
| A11642 | 30808572 | Dig Liver Dis | Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people. | 2019 | Details |
| A11654 | 30803094 | Microcirculation | Multi-domain analysis of microvascular flow motion dynamics in NAFLD. | 2019 | Details |
| A11661 | 30799179 | Nutr Metab Cardiovasc Dis | Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK. | 2019 | Details |
| A11667 | 30796942 | Prog Cardiovasc Dis | Non-alcoholic fatty liver disease: Prevalence and all-cause mortality according to sedentary behaviour and cardiorespiratory fitness. The HUNT Study. | 2019 | Details |
| A11680 | 30792163 | Arch Med Res | Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis. | 2019 | Details |
| A11684 | 30791778 | Expert Rev Gastroenterol Hepatol | Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. | 2018 | Details |
| A11692 | 30789808 | Int J Vitam Nutr Res | No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11713 | 30781472 | Antioxidants (Basel) | Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. | 2019 | Details |
| A11721 | 30777418 | Rev Med Inst Mex Seguro Soc | Molecular alterations induced by fructose and its impact on metabolic diseases | 2019 | Details |
| A11723 | 30776292 | J Clin Endocrinol Metab | Comorbidities in primary versus secondary school children with obesity and responsiveness to lifestyle intervention. | 2019 | Details |
| A11728 | 30774403 | Diabetes Metab Syndr Obes | The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. | 2019 | Details |
| A11730 | 30773868 | Zhen Ci Yan Jiu | [Progress of researches on acupuncture treatment of diseases by regulating endoplasmic reticulum stress]. | 2019 | Details |
| A11741 | 30770030 | Diab Vasc Dis Res | Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. | 2019 | Details |
| A11744 | 30769007 | J Hepatol | The degree of hepatic steatosis associates with impaired cardiac and autonomic function. | 2019 | Details |
| A11752 | 30766413 | Fed Pract | Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans. | 2019 | Details |
| A11757 | 30763931 | Cerebrovasc Dis | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients. | 2019 | Details |
| A11788 | 30744645 | Lipids Health Dis | Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study. | 2019 | Details |
| A11806 | 30732555 | Eur J Sport Sci | Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. | 2019 | Details |
| A11808 | 30731283 | Atherosclerosis | Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. | 2019 | Details |
| A11811 | 30729382 | Curr Obes Rep | Obesity in South Asia: Phenotype, Morbidities, and Mitigation. | 2019 | Details |
| A11814 | 30724128 | Physiology (Bethesda) | Impact of Lipotoxicity on Tissue "Cross Talk" and Metabolic Regulation. | 2019 | Details |
| A11835 | 30714632 | Aliment Pharmacol Ther | Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside. | 2019 | Details |
| A11838 | 30712318 | Liver Int | Ideal cardiovascular health metrics and the risk of non-alcoholic fatty liver disease: A cross-sectional study in northern China. | 2019 | Details |
| A11852 | 30708071 | Diabetes Metab | Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications. | 2019 | Details |
| A11859 | 30706422 | Drugs | L-Ornithine L-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11863 | 30705499 | Clin Diabetes | Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality. | 2019 | Details |
| A11867 | 30703836 | Dtsch Med Wochenschr | [The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]. | 2019 | Details |
| A11869 | 30703416 | Pharmacol Ther | Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. | 2019 | Details |
| A11881 | 34267963 | Florence Nightingale Hemsire Derg | [Is There an Effect of Dietary Fructose on Development and Prognosis of Chronic Diseases?] | 2019 | Details |
| A11888 | 30694825 | Curr Opin Endocrinol Diabetes Obes | Dyslipidemia in nonalcoholic fatty liver disease. | 2019 | Details |
| A11905 | 30686780 | Cell Mol Gastroenterol Hepatol | Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism. | 2018 | Details |
| A11907 | 30685917 | Zhonghua Gan Zang Bing Za Zhi | [Prevalence and harm of nonalcoholic fatty liver disease]. | 2019 | Details |
| A11921 | 30681159 | J Inherit Metab Dis | Choline-related-inherited metabolic diseases-A mini review. | 2019 | Details |
| A11923 | 30680827 | Int J Exp Pathol | Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model. | 2019 | Details |
| A11925 | 30680007 | Exp Ther Med | Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD. | 2018 | Details |
| A11963 | 30666458 | Arch Virol | Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. | 2019 | Details |
| A11983 | 30658519 | Int J Mol Sci | Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. | 2019 | Details |
| A11984 | 30658483 | Nutrients | A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A11990 | 30655210 | Hipertens Riesgo Vasc | [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population]. | 2019 | Details |
| A11998 | 30652643 | Curr Pharm Des | The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12011 | 30645665 | Internist (Berl) | [New aspects of nonalcoholic steatohepatitis]. | 2019 | Details |
| A12042 | 30626749 | JCI Insight | The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity. | 2019 | Details |